Andrew Callos

EVP, Chief Commercial Officer, Cytokinetics

Bought, 12 months

$0.0M

Sold, 12 months

$16.0M

Companies

Latest trade

Aug 31, 2026

Companies

CytokineticsEVP, Chief Commercial Officer −$16.0M

Trades

CYTK Sold 10,000 shares at $70.24 · planned $0.7M Aug 31

CYTK Sold 14,000 shares at $79.88 · planned $1.1M Jul 30

CYTK Sold 15,000 shares at $85.80 · planned $1.3M Jul 1

CYTK Sold 15,000 shares at $74.08 · planned $1.1M Jun 1

CYTK Sold 11,333 shares at $77.25 · planned $0.9M May 5

CYTK Sold 15,857 shares at $65.00 · planned $1.0M May 1

CYTK Sold 15,000 shares at $63.26 · planned $0.9M Apr 30

CYTK Sold 7,449 shares at $66.02 · planned $0.5M Apr 15

CYTK Sold 3,639 shares at $65.00 · planned $0.2M Mar 31

CYTK Sold 1,930 shares at $62.07 · planned $0.1M Mar 18

CYTK Sold 8,542 shares at $62.15 $0.5M Mar 17

CYTK Sold 1,709 shares at $61.03 · planned $0.1M Mar 16

CYTK Sold 2,582 shares at $60.72 $0.2M Mar 9

CYTK Sold 26,000 shares at $61.87 · planned $1.6M Mar 5

CYTK Sold 886 shares at $61.62 · planned $0.1M Mar 2

CYTK Sold 15,000 shares at $61.93 · planned $0.9M Feb 5

CYTK Sold 886 shares at $62.10 · planned $0.1M Feb 2

CYTK Sold 15,000 shares at $60.28 · planned $0.9M Jan 5

CYTK Sold 1,798 shares at $62.62 · planned $0.1M Jan 2

CYTK Sold 1,809 shares at $62.44 · planned $0.1M Dec 29

CYTK Sold 1,042 shares at $65.96 · planned $0.1M Dec 8

CYTK Sold 52,486 shares at $65.95 · planned $3.5M Dec 5

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.